nocathiacin I analogs (Merck & Co)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenocathiacin I analogs (Merck & Co)
Drug Alias Namethiazomycin
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsEnterococcus faecium infectionsEnterococcus Faecalis InfectionsStaphylococcal Infections +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co Inc
Active IndicationsN/A
Inactive IndicationsEnterococcus faecium infectionsEnterococcus Faecalis InfectionsStaphylococcal Infections +[5] 

Other Information

ATC CodeN/A
Related LinksN/A